4th Jun 2025 15:49
Biotech Growth Trust PLC - biotechnology-focused investor - Non-Executive Director Roger Yates buys 10,000 shares at 747.36 pence each, worth GBP74,736, on Wednesday. Earlier on Wednesday, the company said its net asset value declined during its most recent financial year, as market volatility weighs on investor appetite. Net asset value per share at March 31 was 815.9 pence, down 24% from 1,078.9p a year before. NAV total return for the year that ended March 31 was negative 24%, compared to a negative 6.0% return on its benchmark index, the Nasdaq Biotechnology Index.
Current stock price: 743.68 pence, up 1.0% in London on Wednesday afternoon
12-month change: down 22%
By Michael Hennessey, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Biotech Gwth